Harrisburg University Pharmaceutical Sciences Professor Dr. Erik Hefti recently discussed the latest COVID-19 vaccine development with abc27 news.
In the story, “Pa. teachers expected to move into Phase 1A of state vaccine rollout as Johnson & Johnson vaccine approved,” Hefti weighed in on the development of a new vaccine by Johnson & Johnson.
Unlike previously introduced vaccines, Johnson & Johnson’s vaccine only requires a single dose. The vaccine boasts an 85 percent effectiveness against severe COVID-19 cases, according to abc27. However, its effectiveness decreased to 66 percent when tested against moderate cases during testing trials, according to the story. Still, from a logistical standpoint, Johnson & Johnson’s vaccine can be stored longer and doesn’t require ultra-low temperatures, according to abc27.
“All of those factors will continue to bode well for the vaccination efforts in Pennsylvania which have struggled,” Hefti said.
To view the story, follow this link. To learn more about Harrisburg University’s Pharmaceutical Sciences program, click here.
ABOUT HARRISBURG UNIVERSITY
Accredited by the Middle States Commission on Higher Education, Harrisburg University is a private nonprofit university offering bachelor and graduate degree programs in science, technology, and math fields. For more information on the University’s affordable demand-driven undergraduate and graduate programs, call 717-901-5146 or email, Connect@HarrisburgU.edu. Follow on Twitter (@HarrisburgU) and Facebook (Facebook.com/HarrisburgU).
